Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Long-Term Safety Study of Dupilumab for Children and Teens with Atopic Dermatitis
CzechiaStudy on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis
BelgiumStudy on Rheumatoid Arthritis: Evaluating Methotrexate, Golimumab, and Hydroxychloroquine Sulfate for Patients with Autoantibodies and Response to Glucocorticoids
The NetherlandsStudy on the Safety and Effects of RLYB212 in Pregnant Women at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
BelgiumStudy of Leniolisib for Children Aged 4 to 11 with Activated PI3K Delta Syndrome
FranceStudy on the Safety of ATreg Cells for Patients with Leukemia After Stem Cell Transplant to Reduce Graft vs Host Disease
GermanyStudy on Mepolizumab and Drug Combination for Patients with Eosinophilic Granulomatosis with Polyangiitis
FranceStudy on the Effects of Dexmedetomidine on Neuroinflammation in COVID-19 ARDS Survivors
FranceStudy on Tralokinumab and Topical Corticosteroids for Children and Infants with Moderate-to-Severe Atopic Dermatitis
BelgiumStudy on the Effectiveness of Human Normal Immunoglobulin for Treating Painful Nerve Damage in Patients with Primary Sjögren's Syndrome
FranceStudy on Anifrolumab for Patients with Primary Sjogren's Syndrome
The NetherlandsStudy on the Safety and Effectiveness of AZD7798 for Adults with Ileal Crohn's Disease and an Ileostomy
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
